Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1

por Islam, Syed S., Uddin, Mohammed, Noman, Abu Shadat M., Akter, Hosneara, Dity, Nusrat J., Basiruzzman, Mohammad, Uddin, Furkan, Ahsan, Jahanara, Annoor, Sunera, Alaiya, Ayodele A., Al-Alwan, Monther, Yeger, Herman, Farhat, Walid A.
Publicado 2019